Network Meta-Analysis of Novel Glucose-Lowering Drugs on Risk of Acute Kidney Injury

医学 2型糖尿病 利西塞纳泰德 内科学 优势比 荟萃分析 急性肾损伤 糖尿病 置信区间 相对风险 重症监护医学 药理学 利拉鲁肽 内分泌学
作者
Zhao Min,Shusen Sun,Zhenguang Huang,Tiansheng Wang,Huilin Tang
出处
期刊:Clinical Journal of The American Society of Nephrology [Lippincott Williams & Wilkins]
卷期号:16 (1): 70-78 被引量:72
标识
DOI:10.2215/cjn.11220720
摘要

Background and objectives Little is known about the comparative effects of dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide-1 receptor agonists (GLP-1RAs), or sodium glucose cotransporter-2 (SGLT2) inhibitors on risk of AKI. This study aimed to compare the effects of these three novel classes of glucose-lowering drugs on AKI risk in patients with or without type 2 diabetes, by network meta-analysis of event-driven cardiovascular or kidney outcome trials. Design, setting, participants, & measurements We systematically searched electronic databases up to September 2020, and included 20 event-driven cardiovascular or kidney outcome trials (18 trials included patients with type 2 diabetes only, and two trials included patients with or without type 2 diabetes). A network meta-analysis using a frequentist approach was performed to compare the effects of DPP-4 inhibitors, GLP-1RAs, or SGLT2 inhibitors on risk of AKI, and estimate the probability for each intervention as the safest one. The primary analysis included 18 trials with type 2 diabetes only, and a secondary analysis included 20 trials. Results In the 18 trials with a total of 2051 AKI events (range: 1–300) among 156,690 patients with type 2 diabetes only, our network meta-analysis showed that SGLT2 inhibitors were associated with a lower risk of AKI compared with placebo (odds ratio, 0.76; 95% confidence interval, 0.66 to 0.88), whereas both DPP-4 inhibitors and GLP-1RAs had neutral effects on risk of AKI. Moreover, SGLT2 inhibitors were significantly associated with a lower risk in AKI than both GLP-1RAs (odds ratio, 0.79; 95% confidence interval, 0.65 to 0.97) and DPP-4 inhibitors (odds ratio, 0.68; 95% confidence interval, 0.54 to 0.86). SGLT2 inhibitors have the highest probability of being the safest intervention (84%). The results were similar in the secondary analysis. Conclusions Current evidence indicates that SGLT2 inhibitors have a lower risk of AKI than both DPP-4 inhibitors and GLP-1RAs.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
Jasper应助mouxq采纳,获得10
1秒前
超帅花瓣完成签到,获得积分10
1秒前
huoyan2006应助彩色的电脑采纳,获得10
1秒前
qq完成签到,获得积分10
1秒前
李总要发财小苏发文章完成签到,获得积分10
1秒前
量子星尘发布了新的文献求助30
2秒前
sdl发布了新的文献求助10
2秒前
小巧满天完成签到 ,获得积分10
2秒前
roaring完成签到,获得积分10
2秒前
3秒前
weadu完成签到,获得积分10
3秒前
lalaland完成签到,获得积分10
3秒前
在水一方应助asd采纳,获得10
4秒前
johnnwick发布了新的文献求助10
4秒前
欣慰的星月完成签到,获得积分10
4秒前
我是老大应助jituher采纳,获得10
5秒前
JamesPei应助药小博采纳,获得10
5秒前
小刘恨香菜完成签到,获得积分10
5秒前
勿忸发布了新的文献求助10
6秒前
松松小白完成签到,获得积分10
6秒前
Cc关注了科研通微信公众号
6秒前
7秒前
7秒前
杰柒发布了新的文献求助10
7秒前
yc发布了新的文献求助10
7秒前
111舒舒完成签到 ,获得积分10
8秒前
Felix发布了新的文献求助10
8秒前
仄9发布了新的文献求助10
9秒前
9秒前
人福药业完成签到,获得积分10
9秒前
长生的落叶完成签到,获得积分10
10秒前
ljxx发布了新的文献求助10
10秒前
yznfly应助帅帅采纳,获得30
10秒前
之乡坞发布了新的文献求助500
11秒前
11秒前
李白白白完成签到,获得积分10
12秒前
12秒前
汉堡包应助ladette采纳,获得10
12秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3969383
求助须知:如何正确求助?哪些是违规求助? 3514211
关于积分的说明 11172730
捐赠科研通 3249476
什么是DOI,文献DOI怎么找? 1794909
邀请新用户注册赠送积分活动 875441
科研通“疑难数据库(出版商)”最低求助积分说明 804827